Compare OGN & NPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGN | NPO |
|---|---|---|
| Founded | 1923 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 5.3B |
| IPO Year | 2020 | 2002 |
| Metric | OGN | NPO |
|---|---|---|
| Price | $6.12 | $254.16 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $11.75 | ★ $278.33 |
| AVG Volume (30 Days) | ★ 3.2M | 215.5K |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.32% | 0.50% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.72 | ★ 1.91 |
| Revenue | ★ $6,216,000,000.00 | $1,532,000,000.00 |
| Revenue This Year | $0.42 | $12.31 |
| Revenue Next Year | $1.67 | $6.39 |
| P/E Ratio | ★ $8.42 | $132.61 |
| Revenue Growth | N/A | ★ 16.98 |
| 52 Week Low | $5.69 | $135.85 |
| 52 Week High | $13.25 | $286.35 |
| Indicator | OGN | NPO |
|---|---|---|
| Relative Strength Index (RSI) | 42.43 | 51.58 |
| Support Level | $5.69 | $208.99 |
| Resistance Level | $7.87 | $263.18 |
| Average True Range (ATR) | 0.28 | 9.55 |
| MACD | 0.07 | 0.55 |
| Stochastic Oscillator | 62.68 | 64.59 |
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Enpro Inc formerly EnPro Industries Inc is a United States-based company that designs, develops, manufactures, and markets proprietary engineered industrial products. The company operates through two segments: Sealing Technologies, which derives maximum revenue, manufactures and markets sealing products, wheel-end components & systems; and Advanced Surface Technologies, which manufactures wafer processing sub-systems, thin-film coatings, optical filters, and other services like cleaning, coating, testing, and refurbishment. Its geographical segments are the United States, Europe, and other foreign countries.